SCCM Resource Library-Strategies During NeuroMuscular Blocking Agent (NMBA) Shortages

Video Transcription

Video Summary

Dr. Liza Barbarello-Andrews discusses strategies to mitigate shortages of neuromuscular blocking agents (NMBAs) during the COVID-19 pandemic. Cis-etrikerium is the most ideal NMBA, but it is also the most severely affected by shortages. Rocuronium and vecuronium are alternative options, but they have less desirable characteristics. It is important to use the most optimal agent available in a targeted manner. Continuous infusions of NMBAs should only be used when intermittent therapy fails. Patient characteristics should be considered when selecting an agent. Mitigation strategies should prioritize intermittent therapy, provide guidance for agent selection, and reinforce best practices related to titration and adjunctive therapies.

Asset Subtitle

Crisis Management, Pharmacology, 2020

Asset Caption

"This presentation covers how to manage neuromuscular blocking agent (NMBA) shortages.

This is SCCM curated COVID-19 microlearning content."

Meta Tag

Content Type Presentation

Knowledge Area Crisis Management

Knowledge Area Pharmacology

Knowledge Level Intermediate

Knowledge Level Advanced

Membership Level Nonmember

Membership Level Associate

Membership Level Professional

Membership Level Select

Tag Resource Allocation

Tag Analgesia and Sedation

Year 2020

Keywords

neuromuscular blocking agents

shortages

COVID-19 pandemic

Cis-etrikerium

intermittent therapy

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.